The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation.

Góralczyk, Alicja; Kolossa, Katarzyna; Waszczak-Jeka, Marzena; Adamczak, Rafal; Jeka, Slawomir

Góralczyk, Alicja; Kolossa, Katarzyna; Waszczak-Jeka, Marzena; Adamczak, Rafal; Jeka, Slawomir.

Afiliação

Góralczyk A; Department of Rheumatology and Connective Tissue Diseases, University Hospital No. 2, Bydgoszcz, Poland.
Kolossa K; Department of Rheumatology and Connective Tissue Diseases, University Hospital No. 2, Bydgoszcz, Poland.
Waszczak-Jeka M; Medycyna Kliniczna, Warsaw, Poland.
Adamczak R; Department of Obstetrics and Gynaecology, University Hospital No. 2, Bydgoszcz, Poland.
Jeka S; Department of Rheumatology and Connective Tissue Diseases, University Hospital No. 2, Bydgoszcz, Poland.

Postepy Dermatol Alergol ; 37(3): 306-312, 2020 Jun.

Article em En | MEDLINE | ID: mdl-32774212

Palavras-chave

bDMARDs; inflammatory disease; lactation; pregnancy; tsDMARDs

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Postepy Dermatol Alergol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google